comparemela.com

BERKELEY, Calif.--(BUSINESS WIRE)--Insamo, a biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides, today announced $12 million in seed capital from Playground Global, venBio, and MRL Ventures Fund (MRLV). MRLV is a corporate venture arm of Merck & Co., Inc which i...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Sydney ,New South Wales ,Australia ,United States ,Berkeley ,California ,Tokyo ,Japan ,Timothy Craven ,Matt Hershenson ,David Baker ,Tim Craven ,Katja Gagen ,Toby Passioura ,Corey Goodman ,Hiroaki Suga ,Glen Mcintyre ,University Of Washington ,Ventures Fund ,University Of Tokyo ,Merck Co Inc ,Playground Global ,Sahsen Ventures ,Civilization Ventures ,Axial Ventures ,Bio Partners ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.